PRKDC and head and neck squamous cell carcinoma: Evidence using the DNA-Pkcs inhibitor NU7441 has further demonstrated the effectiveness of targeting DNA-Pkcs in radiosensitising three HPV-negative in addition to three HPV-positive HNSCC cell lines[27], suggesting that this is a more general strategy for treatment of HNSCC.